Long Read Sequencing Market Size Worth $4.40 Billion By 2030 | CAGR: 14.4%

The global long read sequencing market size is expected to reach USD 4.40 billion by 2030 according to a new study by Polaris Market Research. The report “Long Read Sequencing Market Share, Size, Trends, Industry Analysis Report, By Technology (Single-Molecule Real-Time Sequencing, Nanopore Sequencing); By Product; By Application; By Workflow; By End-Use; By Region; Segment Forecast, 2022 - 2030” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Innovations and advancements by a key player in technologies to summit the mandate posed by the market are propelling the growth of the long-read sequencing market. Several research studies are arising which are supposed to make a modest rise for producers to create new and advanced technologies and contribute to various opportunities in long-read sequencing. The main application, such as peeling off the need to cut up and then amplify DNA which is generally required in other DNA sequencing techniques, contributes to the growth.

Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/long-read-sequencing-market/request-for-sample

Utilization of long-read sequencing for inventions of vaccines and medicines required for the Covid-19 virus has driven the long-read sequencing market, impacting the positive growth of the Covid -19 pandemic. An increasing number of mandatory Covid-19 testing according to rules and regulations increased the vaccine requirement leading to the development of the long-read sequencing market.

Long Read Sequencing Market Report Highlights

• The single-molecule real-time sequencing account for the largest market and is also expected to grow fastest over the forecast due to its longer read length and low systematic bias achieving high consensus accuracy.
• The long-read sequencing market is categorized as instruments, consumables, and services based on product. The consumables segment accounts for the largest market share in 2021. As in sequencing, it utilizes SMRT cells and SMRT sequencing reagents required for on-instrument sequencing improving software and computational equipment.
• Based on the application, the cancer segment accounted for the largest market share and is supposed to be the fastest growing segment over the forecast period. SMART sequencing is being used in research of hepatitis C virus, hepatitis B virus, HIV, influenza, and other disease-causing microbes.
• Advancements in data analysis tools and significant players expanding their market presence are anticipated for the market's growth. The sequencing segment accounts for the most critical long-read sequencing market share.
• Utilization of sequence analysis method in research, on-site bioinformatics classes offered by universities, and academic workshops have increased, increasing the growth of the long-read sequencing market. 
• There is a rapid increase in genomic procedures for clinical and academic use in the U.S. in North America, increasing the market share for this region. The Asia Pacific is anticipated for the fastest growing area for the long-read sequencing market.
• The global market is highly competitive owing to the existence of large industry players with global presence BaseClear B.V., Future Genomics Technologies B.V., Garvan Institute of Medical Research, Genome Transcriptome Facility of Bordeaux, Institute of Integrative Biology of the Cell (I2BC), MicrobesNG, NextOmics, Oxford Nanopore Technologies Limited, Pacific Biosciences of California, Inc., Quantapore, Inc., Stratos Genomics, Inc., Takara Bio, Inc.

Polaris Market Research has segmented the long read sequencing market report based on, technology, product, application, work-flow, end-uses, and regions:

Long Read Sequencing, Technology Outlook (Revenue - USD Billion, 2018 - 2030)

• Single-Molecule real-time sequencing
• Nanopore sequencing

Long Read Sequencing, Product Outlook (Revenue - USD Billion, 2018 - 2030)

• Instruments
• Consumables
• Services

Long Read Sequencing, Application Outlook (Revenue - USD Billion, 2018 - 2030)

• Identification and fine mapping of structural variation
• Tandem repeat sequencing
• Pseudogene discrimination
• Resolving allele phasing
• Reproductive genomics
• Cancer
• Viral and microbial sequencing
• Others

Long Road Sequencing, Work-Flow Outlook (Revenue - USD Billion, 2018 - 2030)

• Pre-sequencing
• Sequencing
• Data analysis

Long Read Sequencing, End Use Outlook (Revenue - USD Billion, 2018 - 2030)

• Academic research
• Clinical research
• Hospitals and Clinics
• Pharma and Biotech entities
• Others

Long Read Sequencing, Regional Outlook (Revenue - USD Billion, 2018 - 2030)

• North America
  • U.S
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
• Latin America
  • Argentina
  • Brazil
  • Mexico
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa